1 | acute | 56,200 |
2 | hyperacute | 52 |
3 | non-acute | 50 |
4 | 'acute | 28 |
5 | tophaceous | 20 |
6 | hrv-associated | 13 |
7 | shuang-qi | 11 |
8 | bisphosphonate-related | 8 |
9 | ketamine-associated | 8 |
10 | bisphosphonate-associated | 7 |
11 | antimicrobial-associated | 6 |
12 | beta-blocker-induced | 6 |
13 | neuroimaging-negative | 5 |
14 | asparaginase-related | 4 |
15 | exercise-inducible | 4 |
16 | parahisian | 4 |
17 | post-tissue | 4 |
18 | crystal-proven | 3 |
19 | gaze-modulated | 3 |
20 | saturnine | 3 |
21 | 2-acute | 2 |
22 | 4,411 | 2 |
23 | active-phase | 2 |
24 | bupivacaine-induced | 2 |
25 | doxorubicin-associated | 2 |
26 | eccentric-exercise-induced | 2 |
27 | hyperexcitatory | 2 |
28 | life-bronchiectasis | 2 |
29 | mpo-anca-associated | 2 |
30 | mri-proven | 2 |
31 | partially-treated | 2 |
32 | post-acne | 2 |
33 | postobturation | 2 |
34 | progredient | 2 |
35 | small-focal | 2 |
36 | trastuzumab-associated | 2 |
37 | y113h | 2 |
38 | 'treatment-failure | 1 |
39 | 139,305 | 1 |
40 | acute/secretory | 1 |
41 | alkhumra | 1 |
42 | amps’ | 1 |
43 | biokovo | 1 |
44 | bisphosphonates-related | 1 |
45 | bronchiectasic | 1 |
46 | cll/small | 1 |
47 | erosive- | 1 |
48 | exudtaive | 1 |
49 | hepatocyte-directed | 1 |
50 | hs-sultan | 1 |
51 | interred | 1 |
52 | issnhl-related | 1 |
53 | kcn-sensitive | 1 |
54 | lingkong | 1 |
55 | lower-velocity | 1 |
56 | mansonian | 1 |
57 | measles-induced | 1 |
58 | micro-fabricated | 1 |
59 | mildmoderate | 1 |
60 | noninlasive | 1 |
61 | pai-1/tissue-type | 1 |
62 | proven/suspected | 1 |
63 | slowly-progressing | 1 |
64 | tochal | 1 |
65 | vzv-related | 1 |
66 | wheezing-associated | 1 |
67 | ω-type | 1 |
1 | 'acute | 28 |
2 | 'treatment-failure | 1 |
3 | 139,305 | 1 |
4 | 2-acute | 2 |
5 | 4,411 | 2 |
6 | active-phase | 2 |
7 | acute | 56,200 |
8 | acute/secretory | 1 |
9 | alkhumra | 1 |
10 | amps’ | 1 |
11 | antimicrobial-associated | 6 |
12 | asparaginase-related | 4 |
13 | beta-blocker-induced | 6 |
14 | biokovo | 1 |
15 | bisphosphonate-associated | 7 |
16 | bisphosphonate-related | 8 |
17 | bisphosphonates-related | 1 |
18 | bronchiectasic | 1 |
19 | bupivacaine-induced | 2 |
20 | cll/small | 1 |
21 | crystal-proven | 3 |
22 | doxorubicin-associated | 2 |
23 | eccentric-exercise-induced | 2 |
24 | erosive- | 1 |
25 | exercise-inducible | 4 |
26 | exudtaive | 1 |
27 | gaze-modulated | 3 |
28 | hepatocyte-directed | 1 |
29 | hrv-associated | 13 |
30 | hs-sultan | 1 |
31 | hyperacute | 52 |
32 | hyperexcitatory | 2 |
33 | interred | 1 |
34 | issnhl-related | 1 |
35 | kcn-sensitive | 1 |
36 | ketamine-associated | 8 |
37 | life-bronchiectasis | 2 |
38 | lingkong | 1 |
39 | lower-velocity | 1 |
40 | mansonian | 1 |
41 | measles-induced | 1 |
42 | micro-fabricated | 1 |
43 | mildmoderate | 1 |
44 | mpo-anca-associated | 2 |
45 | mri-proven | 2 |
46 | neuroimaging-negative | 5 |
47 | non-acute | 50 |
48 | noninlasive | 1 |
49 | pai-1/tissue-type | 1 |
50 | parahisian | 4 |
51 | partially-treated | 2 |
52 | post-acne | 2 |
53 | post-tissue | 4 |
54 | postobturation | 2 |
55 | progredient | 2 |
56 | proven/suspected | 1 |
57 | saturnine | 3 |
58 | shuang-qi | 11 |
59 | slowly-progressing | 1 |
60 | small-focal | 2 |
61 | tochal | 1 |
62 | tophaceous | 20 |
63 | trastuzumab-associated | 2 |
64 | vzv-related | 1 |
65 | wheezing-associated | 1 |
66 | y113h | 2 |
67 | ω-type | 1 |
1 | erosive- | 1 |
2 | 4,411 | 2 |
3 | 139,305 | 1 |
4 | alkhumra | 1 |
5 | bronchiectasic | 1 |
6 | bupivacaine-induced | 2 |
7 | eccentric-exercise-induced | 2 |
8 | beta-blocker-induced | 6 |
9 | measles-induced | 1 |
10 | interred | 1 |
11 | micro-fabricated | 1 |
12 | partially-treated | 2 |
13 | mpo-anca-associated | 2 |
14 | trastuzumab-associated | 2 |
15 | ketamine-associated | 8 |
16 | bisphosphonate-associated | 7 |
17 | wheezing-associated | 1 |
18 | antimicrobial-associated | 6 |
19 | doxorubicin-associated | 2 |
20 | hrv-associated | 13 |
21 | asparaginase-related | 4 |
22 | bisphosphonate-related | 8 |
23 | issnhl-related | 1 |
24 | bisphosphonates-related | 1 |
25 | vzv-related | 1 |
26 | gaze-modulated | 3 |
27 | proven/suspected | 1 |
28 | hepatocyte-directed | 1 |
29 | exercise-inducible | 4 |
30 | post-acne | 2 |
31 | saturnine | 3 |
32 | pai-1/tissue-type | 1 |
33 | ω-type | 1 |
34 | 'treatment-failure | 1 |
35 | active-phase | 2 |
36 | mildmoderate | 1 |
37 | acute | 56,200 |
38 | 'acute | 28 |
39 | 2-acute | 2 |
40 | non-acute | 50 |
41 | hyperacute | 52 |
42 | post-tissue | 4 |
43 | exudtaive | 1 |
44 | noninlasive | 1 |
45 | neuroimaging-negative | 5 |
46 | kcn-sensitive | 1 |
47 | slowly-progressing | 1 |
48 | lingkong | 1 |
49 | y113h | 2 |
50 | shuang-qi | 11 |
51 | small-focal | 2 |
52 | tochal | 1 |
53 | cll/small | 1 |
54 | mansonian | 1 |
55 | parahisian | 4 |
56 | hs-sultan | 1 |
57 | mri-proven | 2 |
58 | crystal-proven | 3 |
59 | postobturation | 2 |
60 | biokovo | 1 |
61 | life-bronchiectasis | 2 |
62 | tophaceous | 20 |
63 | progredient | 2 |
64 | hyperexcitatory | 2 |
65 | acute/secretory | 1 |
66 | lower-velocity | 1 |
67 | amps’ | 1 |